Juba would be the founding father of angioClast, a Cambridge-dependent biotech startup focused on most cancers study. Before entrepreneurship, Juba was a seasoned CFO with multi-market practical experience and worked on jobs, ranging from an equity sale of the $150 million telecom enterprise to your $50 million hotel enterprise turnaround.Toptal's